Menu Search
Equities

Sensus Healthcare Inc

5TX:DUS

Sensus Healthcare Inc

Actions
  • Price (EUR)6.25
  • Today's Change0.25 / 4.17%
  • Shares traded--
  • 1 Year change+207.58%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Sensus Healthcare Inc's revenues fell -45.20% from 44.53m to 24.41m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 24.24m to 485.00k, a -98.00% decrease.
Gross margin60.23%
Net profit margin18.27%
Operating margin23.51%
Return on assets12.06%
Return on equity13.44%
Return on investment13.25%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Sensus Healthcare Inc fell by 2.37m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 2.15m for operations while cash used for investing totalled 187.00k.
Cash flow per share0.421
Price/Cash flow per share16.16
Book value per share3.23
Tangible book value per share3.23
More ▼

Balance sheet in USDView more

Sensus Healthcare Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio11.63
Quick ratio8.20
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.